© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Pulmonx Corporation (LUNG) shows an Average True Range (ATR) of 0.19 and an Enterprise Value of 247.44M. Its average trading volume over the past 3 months is 2.46M, indicating liquidity. These fundamental metrics provide insight into LUNG's underlying financial health and market activity.
Pulmonx Corporation (LUNG) technical indicators as of December 22, 2025: the SMA 20 is 23.63%, SMA 50 at 40.8%, and SMA 200 at -14.35%. The RSI 14 value is 70.45, suggesting its current momentum. These technical analysis signals help assess LUNG's price trends and potential future movements.
Pulmonx Corporation (LUNG) stock performance overview as of December 22, 2025: The 52-week high is $9.37 (currently -72.25% below), and the 52-week low is $1.31 (currently 98.47% above). Over the past year, LUNG's performance is -57.38%, compared to the S&P 500's 12.87% change.
According to market data, Pulmonx Corporation (LUNG) stock's recent performance metrics show that over the last month, LUNG is 85.71%, with a Year-to-Date (YTD) performance of -61.71%. Over the past year, the stock has seen a -57.38% change. These figures summarize LUNG's price movements across various periods, reflecting its historical returns.
According to current financial data, LUNG stock's P/E (TTM) ratio is -1.84, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for LUNG, including P/S (1.18), P/B (1.51), and P/FCF (-3.35), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.